Ikarian Capital, LLC Biomea Fusion, Inc. Call Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.92 - $19.5 $4.18 Million - $5.85 Million
300,000 Added 38.58%
1,077,600 $16.1 Million
Q4 2023

Feb 14, 2024
BUY
$8.37 - $19.8 $6.51 Million - $15.4 Million
777,600 New
777,600 $11.3 Million
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $14 Million - $27 Million
645,800 Added 221.92%
936,800 $20.6 Million
Q1 2023

May 15, 2023
BUY
$6.8 - $32.35 $1.98 Million - $9.41 Million
291,000 New
291,000 $9.02 Million

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $117M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email